41 related articles for article (PubMed ID: 35178197)
21. Estimating The Annual Abortion Rate in Kerman, Iran: Comparison of Direct, Network Scale-Up, and Single Sample Count Methods.
Zamanian M; Zolala F; Haghdoost AA; Baneshi MR
Int J Fertil Steril; 2019 Oct; 13(3):209-214. PubMed ID: 31310075
[TBL] [Abstract][Full Text] [Related]
22. Methodological considerations in using the Network Scale Up (NSU) for the estimation of risky behaviors of particular age-gender groups: An example in the case of intentional abortion.
Zamanian M; Zolala F; Haghdoost AA; Haji-Maghsoudi S; Heydari Z; Baneshi MR
PLoS One; 2019; 14(6):e0217481. PubMed ID: 31185067
[TBL] [Abstract][Full Text] [Related]
23. Transition from First Drug Use to Regular Injection among People Who Inject Drugs in Iran.
Koozegar M; Shahesmaeili A; Noroozi M
Addict Health; 2018 Jan; 10(1):32-40. PubMed ID: 30627383
[TBL] [Abstract][Full Text] [Related]
24. How and Where Do We Ask Sensitive Questions: Self-reporting of STI-associated Symptoms Among the Iranian General Population.
Nasirian M; Hosseini Hooshyar S; Haghdoost AA; Karamouzian M
Int J Health Policy Manag; 2018 Aug; 7(8):738-745. PubMed ID: 30078294
[TBL] [Abstract][Full Text] [Related]
25. Risk Factors for Addiction Potential among College Students.
Ranjbaran M; Mohammadshahi F; Mani S; Karimy M
Int J Prev Med; 2018; 9():17. PubMed ID: 29541432
[TBL] [Abstract][Full Text] [Related]
26. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
[TBL] [Abstract][Full Text] [Related]
27. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran.
Nikfarjam A; Shokoohi M; Shahesmaeili A; Haghdoost AA; Baneshi MR; Haji-Maghsoudi S; Rastegari A; Nasehi AA; Memaryan N; Tarjoman T
Int J Drug Policy; 2016 May; 31():147-52. PubMed ID: 26980349
[TBL] [Abstract][Full Text] [Related]
28. Social network size estimation and determinants in tehran province residents.
Shati M; Haghdoost A; Majdzadeh R; Mohammad K; Mortazavi S
Iran J Public Health; 2014 Aug; 43(8):1079-90. PubMed ID: 25927037
[TBL] [Abstract][Full Text] [Related]
29. Application of a Network Scale-up Method to Estimate the Size of Population of Breast, Ovarian/Cervical, Prostate and Bladder Cancers.
Haghdoost AA; Baneshi MR; Haji-Maghsoodi S; Molavi-Vardanjani H; Mohebbi E
Asian Pac J Cancer Prev; 2015; 16(8):3273-7. PubMed ID: 25921131
[TBL] [Abstract][Full Text] [Related]
30. Estimating the size of HIV key affected populations in Chongqing, China, using the network scale-up method.
Guo W; Bao S; Lin W; Wu G; Zhang W; Hladik W; Abdul-Quader A; Bulterys M; Fuller S; Wang L
PLoS One; 2013; 8(8):e71796. PubMed ID: 23967246
[TBL] [Abstract][Full Text] [Related]
31. The estimation of active social network size of the Iranian population.
Rastegari A; Haji-Maghsoudi S; Haghdoost A; Shatti M; Tarjoman T; Baneshi MR
Glob J Health Sci; 2013 Jun; 5(4):217-27. PubMed ID: 23777738
[TBL] [Abstract][Full Text] [Related]
32. Size Estimation of Groups at High Risk of HIV/AIDS using Network Scale Up in Kerman, Iran.
Shokoohi M; Baneshi MR; Haghdoost AA
Int J Prev Med; 2012 Jul; 3(7):471-6. PubMed ID: 22891148
[TBL] [Abstract][Full Text] [Related]
33. Counting hard-to-count populations: the network scale-up method for public health.
Bernard HR; Hallett T; Iovita A; Johnsen EC; Lyerla R; McCarty C; Mahy M; Salganik MJ; Saliuk T; Scutelniciuc O; Shelley GA; Sirinirund P; Weir S; Stroup DF
Sex Transm Infect; 2010 Dec; 86 Suppl 2(Suppl_2):ii11-5. PubMed ID: 21106509
[TBL] [Abstract][Full Text] [Related]
34. Pattern of tobacco use among the Iranian adult population: results of the national Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007).
Meysamie A; Ghaletaki R; Haghazali M; Asgari F; Rashidi A; Khalilzadeh O; Esteghamati A; Abbasi M
Tob Control; 2010 Apr; 19(2):125-8. PubMed ID: 20008159
[TBL] [Abstract][Full Text] [Related]
35. Determinants of tobacco use among youths in Isfahan, Iran.
Kelishadi R; Mokhtari MR; Tavasoli AA; Khosravi A; Ahangar-Nazari I; Sabet B; Kazemi A; Amini A
Int J Public Health; 2007; 52(3):173-9. PubMed ID: 17958284
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of substance use among Iranian high school students.
Ahmadi J; Hasani M
Addict Behav; 2003 Mar; 28(2):375-9. PubMed ID: 12573688
[TBL] [Abstract][Full Text] [Related]
37. A Review Study of Substance Abuse Status in High School Students, Isfahan, Iran.
Nahvizadeh MM; Akhavan S; Arti S; Qaraat L; Geramian N; Farajzadegan Z; Heidari K
Int J Prev Med; 2014 Dec; 5(Suppl 2):S77-82. PubMed ID: 26157571
[TBL] [Abstract][Full Text] [Related]
38. Drug use and HIV/AIDS in China.
Liu Z; Lian Z; Zhao C
Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
[TBL] [Abstract][Full Text] [Related]
39. Population Size Estimation of Drug Users in Isfahan City (Iran) Using Network Scale-up Method in 2018.
Abshenas-Jami M; Baneshi M; Nasirian M
Addict Health; 2021 Oct; 13(4):249-258. PubMed ID: 35178197
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
